News from the States
Florida: House Wants Medicaid Do-Over more
Maryland: Patients, Insurers to Pay More more
Montana: Governor Schweitzer's New Idea for Cheaper Drugs: The VA more
Tennessee:100,000 People Removed From Medicaid Rolls more
Texas:Texas Introduces Bill to Study PBMs more
Washington: Medicaid Cards in Mail to 1 Million Residents more
|
Outrage of the Week
Who Really Suffers If Pfizer Is Too Big To Fail? more
Feds Found Pfizer Too Big to Nail more
Fines Haven't Stopped Drug Company Lawbreaking -- Maybe Jail Time for Executives Would more
|
Pharmaceutical Pricing
High Blood Pressure Treatment Just Got Cheaper more
Canadian Payers "Reject Over 50% of New Drugs Each Year" more
The QALY Pricing Model Is A Pharma Trick more
US Prescription Sales Rose 5 Percent In 2009 more
|
Pharmaceuticals & Health Reform
Study: VA's Computer Systems Cost Billions, but Have Big Payback more
Health Information at Fisk with File-Sharing Programs more
Health Industry Invests in State Elections more
Sebelius Warns of Health-Insurance Scam more
|
Conflict of Interest & Disclosure
The Challenge Posed By Journal Supplements moreMarketing Often Mars Work Done in Big Pharma Labs morePfizer Gives Details on Payments to Doctors morePfizer Discloses Payments To Doctors moreAllan Coukell On Payments To Doctors & Disclosure moreStill Need Sunshine: Voluntary Disclosures No Sub for National Website moreUniversity of Miami Lists Payments To Docs more |
Advertising and Marketing
U.S. FDA Warns Gilead, Biogen Over Drug Promotions more
Is The FDA Proposal For DTC Ads Too Vague? more
WLF & Pfizer Ask Court to Block FDA Guidance on Social Media more
A Sanofi Drug, A Web Site & Lack Of Disclosure more
The iPad as a Pharma Marketing Platform more
|
Pharma Watch
Scientist Claims Wyeth Deceived Him more
Lilly-Zyprexa: Louisiana gets $20M more
Sanofi's Multaq Is Less Effective Than Rival Drugs more
Former Bristol CFO Wins Ruling In Criminal Case more
SC to Get $12.7 Million Under Deal With Pfizer Inc. Over Sales Tactics more
Federal Judge Refuses to Dismiss Suit in Provigil Antitrust Case more
Drugmakers, FDA & Private Eyes more
Pharma and the Gumshoes, Revisited more
Vietnam Fines Schering-Plough For Kickbacks more
Whatever Happened To The Nemeroff Probe? more
Mirror, Mirror On The Wall... The Biggest Drugmakers more
Pfizer Agrees to First Neurontin Lawsuit Settlement more
|
PBM Watch
Kansas Employee Drug Plan Pricey, Critics say more
Businesses on the Brink: Change or Fail? more
CVS Task Force Probe Includes Connecticut, Illinois more
|
Patents and Generics
Study May Prompt Rethink on Schizophrenia Drugs more
Pfizer Says It's a "Golden Age" For Drug Discovery more
Indian Pharma Decries Patents Granted Pfizer, Novartis more
Generic Business Faces Tougher Slog more
Lilly And Sandoz Lose Preemption Argument more
'Gold Rush Is Over' for Simple Gene Discoveries more
Patents On Genes Are Struck Down By Judge more
Breast Cancer Genes Can't be Patented, Federal Court Rules more
Highly Touted Heart Drug Multaq Not as Good as Generics, Cardiologists Say more
Health Reform Law Gives Biologic Drugs 12-Year Exclusivity more
|
Medicare and Medicaid
New CMS Web Site Shines Light On Medicare Spending more
Bernanke Warns: Trouble Ahead For Medicare And Social Security more
Berwick, Blumenthal May Form Dream Team At CMS more
Medicare Advantage Insurers Won't See Increase In 2011 more
Law Enforcement Officials Seek, Find Medicare Fraud more
States Face Health Care Budget Cuts, Seek Health-Related Legislation more
States Hope New Funding From Health Law Will Bolster Unique Programs more
States Examine How They May Be Impacted By Reform, Medicaid Expansion more
Medicare Plans That Broke Rules Include Familiar Names more
Health Dept. IG Says Six Medicare Advantage Insurers Broke Rules more
Aetna Says U.S. Will Suspend Drug-Plan Enrollments more
|
Safety and Clinical Trials
OxyContin Gets a Safety Makeover more
Novartis, Orion's Stalevo Drug May Have Cancer Risk more
Regulators Reject a Drugmaker's Plan to Use Its Alertness Pill for Jet Lag more
Test Predicts Which Patients Benefit From $6 Billion MS Drugs more
H1N1 Spike in Georgia Raises Concerns of Possible Third Wave more
Chinese Drugmaker Under Criminal Investigation more
U.S. Probes Alleged Seller of Fake J&J Diabetes Monitors more
Complicating Doctors' Work: Prescription Drug Scams And Excessive Paper Work more
FDA Warns Spas About Fat-Reducing Drugs more
Risks Seen in Cholesterol Drug Use in Healthy People more
|
